Amplifica Completes $11.8 Million Series A Financing to Enable Clinical Development of Lead Products to Treat Androgenic Alopecia

SAN DIEGO, Oct. 24, 2022 /PRNewswire/ — Amplifica Holdings Group, Inc. (“Amplifica”), a privately-held, clinical-stage biopharmaceutical company announced it successfully closed an $11.8 million Series A Preferred Stock financing. The company intends to use the funds to advance the…

Click here to view original post